STC1 and ovarian cancer: Various cancers overexpress STC1, and STC1 promotes chemoresistance to cisplatin by directly binding to αvβ6 integrin to activate the PI3K signaling pathway in ovarian cancer cell lines Skov3-ip1 and Hey [44,45] (Figure 3).